| 000 | 01161 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517052413.0 | ||
| 264 | 0 | _c20151215 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a1097-4172 | ||
| 024 | 7 |
_a10.1016/j.cell.2015.08.047 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAllison, James P | |
| 245 | 0 | 0 |
_aCheckpoints. _h[electronic resource] |
| 260 |
_bCell _cSep 2015 |
||
| 300 |
_a1202-5 p. _bdigital |
||
| 500 | _aPublication Type: Autobiography; Historical Article; Journal Article; Portrait | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _xantagonists & inhibitors |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHistory, 20th Century |
| 650 | 0 | 4 | _aHistory, 21st Century |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xhistory |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aNeoplasms _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tCell _gvol. 162 _gno. 6 _gp. 1202-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cell.2015.08.047 _zAvailable from publisher's website |
| 999 |
_c25251536 _d25251536 |
||